Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: Double-blind, randomized, controlled study

Respiratory Medicine

Volumn 96, Issue 3, 2002, Pages 137-141

  Centanni, S ^a   Santus, P ^a   Casanova, F ^a   Carlucci, P ^a   Boveri, B ^a   Castagna, F ^a   Di Marco, F ^a   Cazzola, M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Acute exacerbation; COPD; Oxitropium bromide

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; HISTAMINE; LEVOFLOXACIN; OXITROPIUM BROMIDE; PLACEBO; STEROID; TERBUTALINE;

ADULT; AGED; ARTICLE; BODY PLETHYSMOGRAPHY; BRONCHODILATING ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MALE; METERED DOSE INHALER; OUTPATIENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMOKING; TREATMENT OUTCOME;

EID: 0036490679     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1219     Document Type: Article

References (34)

1. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: Inpatient management of COPD
3. Acute exacerbations of obstructive lung disease. What to do when immediate care is crucial
4. The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation
5. Aerosol therapy: Nebulized vs metered dose inhaler
6. Dose-response of inhaled drugs in asthma. An update
7. Arrhythmias in patients with chronic obstructive pulmonary disease
8. Cardiac arrhythmias in chronic obstructive pulmonary disease
9. Fenoterol and ipratropium bromide in respirator treatment of patients with chronic bronchitis
10. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airway disease in the emergency room
11. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease
12. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD
13. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments
14. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
15. Toward a consensus definition for COPD exacerbations
16. BTS guidelines for the management of chronic obstructive pulmonary disease
17. Standardization of spirometry; update 1994
18. Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: Variability and sensitivity of a visual analogue scale in patients with asthma or COPD
19. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease
20. Can we justify ipratropium therapy as initial management of acute exacerbations of COPD?
21. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction
22. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
23. Beta-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease
24. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
25. Anticholinergic drugs
26. Arrhythmias associated with acute respiratory failure in patients with chronic obstruction
27. Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease
28. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD
29. Cardiac arrhythmias in patients with mild-to-moderate obstructive pulmonary disease. Comparison of β-agonist therapy alone and in combination with a xanthine derivative, enprophylline or theophylline
30. Cardiovascular effects of fenoterol under conditions of hypoxaemia
31. Physiologic actions of beta-adrenergic agonists
32. The use of anticholinergic drugs in acute exacerbations of chronic obstructive pulmonary disease
33. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD